|
Volumn 82, Issue 3, 2002, Pages 674-682
|
Estrogen-mediated neuroprotection against β-amyloid toxicity requires expression of estrogen receptor α or β and activation of the MAPK pathway
|
Author keywords
amyloid; ERK2; Estrogen; Estrogen receptor; HT22; Neuroprotection
|
Indexed keywords
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
AMYLOID BETA PROTEIN;
ESTRADIOL;
ESTROGEN;
ESTROGEN RECEPTOR ALPHA;
ESTROGEN RECEPTOR BETA;
FULVESTRANT;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE 1;
ALZHEIMER DISEASE;
ARTICLE;
CELL SURVIVAL;
CELL VIABILITY;
CONTROLLED STUDY;
CYTOTOXICITY;
DEGENERATIVE DISEASE;
GENETIC TRANSFECTION;
HIPPOCAMPUS;
HUMAN;
HUMAN CELL;
IMMUNOBLOTTING;
IMMUNOCYTOCHEMISTRY;
NEUROPROTECTION;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
AMYLOID BETA-PROTEIN;
ANIMALS;
CELL LINE;
CELL SURVIVAL;
CYTOPROTECTION;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
ESTRADIOL;
ESTROGEN RECEPTOR ALPHA;
ESTROGEN RECEPTOR BETA;
ESTROGENS;
MAP KINASE SIGNALING SYSTEM;
MICE;
MITOGEN-ACTIVATED PROTEIN KINASE 1;
NEURONS;
PEPTIDE FRAGMENTS;
PHOSPHORYLATION;
RATS;
RECEPTORS, ESTROGEN;
TRANSFECTION;
|
EID: 0036320770
PISSN: 00223042
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1471-4159.2002.01000.x Document Type: Article |
Times cited : (147)
|
References (37)
|